drug price comparison

How to Use Drug Price Comparison to Save on Prescription Costs in 2026

May 12, 2026

Key Takeaways

Compare prices across multiple pharmacies and tools like Inside Rx and pharmacy websites.
Generic medications save 80-85% compared to brand names.
Don't assume insurance always offers the best price.
Review your coverage annually during open enrollment.
Leverage manufacturer coupons and 90-day supplies which typically cost less than three 30-day fills.

Blue-white pills scattered from a jar on American dollars

The Inside Rx Blog

Get the Inside Scoop on tips & tricks that may help your family save on prescriptions!

Subscribe to stay up to date with the latest news and tips

Prescription costs fluctuate significantly across pharmacies, with identical medications showing price variations that directly impact patient expenses. The Inflation Reduction Act establishes negotiated pricing for ten medications effective 2026, delivering minimum savings of 38% below 2023 list prices and reducing annual out-of-pocket expenses by an estimated $1.5 billion for Medicare beneficiaries. Price comparison across pharmacies, medication discount programs, and specialized tools such as Inside Rx enable patients to identify optimal cost structures for their prescriptions. This analysis details pharmacy price comparison methodology and cost reduction strategies for prescription medications.

Understanding drug price negotiation in 2026

What the Inflation Reduction Act means for prescription costs

The Inflation Reduction Act establishes Medicare's authority to negotiate prices directly with pharmaceutical manufacturers for select high-cost medications. This August 2022 legislation eliminates the prior prohibition on Medicare price negotiations. The program focuses on single-source drugs without generic or biosimilar alternatives that generate the highest Medicare expenditures.

Drug selection operates under defined parameters. Small-molecule drugs require FDA approval at least seven years before selection eligibility, while biologic therapies must complete 11 years of market availability. CMS excludes medications with Medicare spending below $200 million, orphan drugs designated for single rare diseases, and plasma-derived products.

Manufacturers submit research and development costs, production data, patent details, and sales information to CMS by February annually. CMS responds with initial price offers by June 1, initiating counter offers and up to three negotiation sessions through spring and summer. The process is finalized by November 1, establishing Maximum Fair Prices (MFPs) under the statute.

The 2026 program encompasses 10 Part D drugs, expanding to 15 additional Part D drugs for 2027, 15 Part B or Part D drugs for 2028, and 20 drugs annually thereafter. Negotiated prices achieved discounts of 38 to 79 percent below list prices. These negotiations would have generated $6 billion in Medicare savings if 2026 prices were applied during 2023, representing 22 percent cost reduction.

Which medications have negotiated prices

The initial 10 negotiated drugs target heart disease, diabetes, autoimmune conditions, and cancer. Included medications are Eliquis for blood clot prevention and treatment, Jardiance for diabetes and heart failure, Xarelto for blood clot prevention, Januvia for diabetes, Farxiga for diabetes and chronic kidney disease, Entresto for heart failure, Enbrel for rheumatoid arthritis and psoriasis, Imbruvica for blood cancers, Stelara for psoriasis and Crohn's disease, and NovoLog/Fiasp insulin products for diabetes.

These medications reached 8.8 million of the 54 million Medicare Part D enrollees during 2023. The selected drugs generated $56.2 billion in total Part D gross covered prescription drug costs, representing 20 percent of annual Part D spending.

Round two introduces 15 medications with prices effective January 1, 2027. This expansion includes Ozempic, Rybelsus, and Wegovy for diabetes and weight management, plus Ibrance for breast cancer, Xtandi for prostate cancer, and Trelegy Ellipta for asthma and COPD. These medications serve 5.3 million beneficiaries and accounted for $42.5 billion in 2024 Medicare Part D spending.

How negotiated prices affect your out-of-pocket costs

Coinsurance payments decline when negotiated prices become effective because Part D plans calculate cost-sharing as drug price percentages. Cost-sharing for the initial 10 drugs will drop approximately 50 percent on average for Part D enrollees.

Consider Stelara pricing: a Medicare beneficiary with 25 percent coinsurance currently pays approximately $3,400 for a 30-day supply. The 2026 negotiated price reduces that same 25 percent coinsurance to roughly $1,100 before catastrophic coverage thresholds.

Medicare prescription drug coverage holders will experience aggregated estimated savings of $1.5 billion in personal out-of-pocket costs during 2026. The second-round negotiated drugs will save Medicare beneficiaries approximately $685 million in out-of-pocket expenses in 2027.

Pharmacy pricing variations persist despite negotiated Medicare prices. Price comparison tools and discount cards such as Inside Rx provide supplementary savings opportunities beyond Medicare negotiations, particularly for medications excluded from current negotiation cycles.

Where to compare prescription drug prices

Multiple platforms enable prescription drug price comparison and cost identification for medications.

Medicare Plan Finder tool

Medicare's Plan Finder tool compares coverage and costs across Medicare Advantage plans and stand-alone prescription drug plans. The system calculates total annual costs for each plan after you input prescription drugs and preferred pharmacies, displaying results with premiums, deductibles, and copays ranked from lowest to highest.

Plan restrictions, star ratings, and preferred pharmacy networks appear within search results for each option. Creating a MyMedicare account optimizes functionality by saving drug lists and search parameters.

Inside Rx drug discount card

Inside Rx maintains partnerships with 60,000 pharmacies nationwide for prescription discounts. Savings reach up to 80%, with average reductions of 78% for generic medications and 37% for select brand-name drugs.

Specific brand medications carry eligibility restrictions. Inside Rx prohibits usage for Medicare, Medicaid, VA, DoD, or Tricare program participants on designated brand-name drugs. Age restrictions affect beneficiaries 65 or older, who cannot use Inside Rx cards for Advair HFA, Breo Ellipta, Flovent Diskus, Anoro Ellipta, Incruse Ellipta, Flovent HFA, Arnuity Ellipta, or Trelegy Ellipta.

Inside Rx cards exclude combination with insurance, copay cards, or secondary payers. Selecting Inside Rx over insurance means medication costs may not count toward deductible or cost-sharing requirements.

GoodRx and discount card platforms

GoodRx operates as a price comparison platform with discount coupons, not insurance coverage. Users follow three steps: search medication prices at local pharmacies, select the pharmacy with optimal pricing, and present the coupon at checkout for discounted cash payment.

GoodRx coupons cannot combine with insurance coverage. Medicare Part D beneficiaries who use GoodRx coupons instead of plan coverage find purchases typically exclude from Part D deductible or out-of-pocket maximum calculations. GoodRx often provides better pricing for generic medications with high plan copays, non-covered drugs, or purchases before high-deductible plan thresholds.

ScriptSave WellRx offers similar functionality with average savings of 75% across more than 54,000 participating pharmacies nationwide.

Pharmacy websites and apps

Major pharmacy chains maintain price lookup tools through websites and mobile applications. These platforms enable direct price comparison before store visits.

Your insurance formulary

Plan formularies specify drug coverage and associated requirements. Medications appear in tiers, with lower tiers requiring reduced out-of-pocket payments. Acronyms such as PA (prior authorization), ST (step therapy), or QL (quantity limits) indicate specific drug restrictions.

Plans designate preferred pharmacies with reduced cost-sharing within their networks. Mail-order pharmacy services provide 90 or 100-day supplies for maintenance medications with direct delivery.

How to use pharmacy drug price comparison effectively

Price analysis across pharmacies exposes significant cost variations that affect patient expenditures. Effective drug price comparison requires evaluation of multiple factors beyond posted prices to identify actual savings opportunities.

Check prices at multiple pharmacies

Pharmacy pricing structures vary based on supplier contracts, inventory management costs, and geographic location. Tools such as Inside Rx enable price comparison between Walmart pharmacy locations and Walgreens chains. Drug discount cards like Inside Rx provide access to contracted rates across 60,000 participating pharmacies, revealing price disparities not apparent through standard inquiries.

Compare brand-name vs generic options

Generic medications cost 80% to 85% less than brand-name equivalents on average. This produces measurable savings: generic drugs reduce consumer costs by $8 to $10 billion annually at retail pharmacies. Specific examples include one-year supplies of branded levetiracetam at $690 versus generic versions at $540, and branded lamotrigine at $900 compared to $600 for generic alternatives.

Physicians typically prescribe generic medications as first-line treatment, with network pharmacies implementing automatic generic substitution when available. Brand-name drug requests requiring generic alternatives mandate prior authorization approval for insurance coverage. Generic substitution rates achieve 91.4% at retail pharmacy locations.

Factor in insurance coverage and deductibles

Plan cost-sharing structures determine whether pharmacy price comparison yields financial benefits. Patients with fixed copayments experience protection from price fluctuations, while those with deductibles see out-of-pocket costs rise by a median of 17.5%. Coinsurance payments increase expenses by a median of 15.8% when drug prices escalate.

Discount cards frequently offer superior pricing compared to insurance when deductibles remain unmet. Discount card payments typically do not contribute toward deductible or out-of-pocket maximum calculations but may provide lower immediate costs than full-price payments before reaching plan thresholds.

Consider mail-order vs retail pharmacy costs

Mail-order pricing demonstrates significant variation by plan type and medication category. Certain contracts show mail-order costs 1% to 38% above retail prices, while others provide cost reductions. Generic medications through mail-order can cost 3% to 83% more than retail prices under specific plans. Brand-name drugs typically cost 1% to 18% less through mail-order services.

Health plan data shows 90-day generic supplies costing $10 through mail-order versus $15 for three 30-day retail purchases. Retail pharmacies demonstrated lower costs for 244 products compared to 56 products where mail-order pharmacies offered advantages.

Additional ways to reduce prescription costs

Several cost reduction strategies extend beyond pharmacy price comparison to decrease medication expenses.

Apply manufacturer coupons and rebates

Pharmaceutical companies provide copay cards and coupons for brand-name medications lacking generic alternatives. These programs target commercial insurance plan participants, reducing post-insurance claim amounts.

Multiple channels provide access to savings programs. Manufacturer websites detail medication-specific programs, while healthcare providers maintain information about available assistance. Databases such as needymeds.org track manufacturer copay assistance programs. Eligibility criteria vary by manufacturer, with some programs restricting usage to single applications, defined time periods, or specific refill quantities.

Medicare and Medicaid regulations classify manufacturer coupons as prohibited kickbacks. Commercial insurance holders may access substantial cost reductions through copay cards, though manufacturer assistance payments typically exclude deductible and out-of-pocket maximum calculations.

Ask about 90-day supply discounts

Extended supply orders reduce per-unit costs through volume pricing structures. Insurance plans frequently establish lower copay rates for 90-day prescriptions compared to three separate 30-day transactions. 90-day generic supply costing $10 through mail-order services versus $15 for equivalent 30-day retail purchases demonstrates typical savings.

Extended supplies eliminate multiple pharmacy visits and reduce administrative processing costs. Retail pharmacy 90-day dispensing increased from under 7% in 2010 to approximately 20% by 2019. Retail and mail-order services both accommodate extended supplies for maintenance medications.

Talk to your doctor about therapeutic alternatives

Generic substitution produces measurable cost reductions for eligible medications. Patients without low-income subsidies save $138 annually per generic substitution. Therapeutic alternatives generate greater benefits: patient savings average $113 annually while health plans save $276 per year.

Data indicates 39% of subsidized Medicare patients and 51% of non-subsidized patients qualify for generic or therapeutic substitution. Healthcare providers can assess whether alternative medications provide equivalent therapeutic outcomes at reduced costs.

Use patient assistance programs

Patient assistance programs (PAPs) supply free or reduced-cost medications to uninsured or underinsured individuals meeting income thresholds. Pharmaceutical manufacturers operate these programs independently from Part D benefits.

The Medicine Assistance Tool provides access to over 900 public and private assistance programs. Income eligibility and application requirements differ by manufacturer, with annual reapplication and healthcare provider documentation frequently required.

Common mistakes to avoid when comparing drug prices

Price comparison errors result in unnecessary medication expenses and missed savings opportunities.

Assuming your insurance always offers the best price

Insurance coverage does not guarantee optimal medication pricing. Up to 10 percent of drug transactions involve scenarios where cash payments produce lower costs than insurance copayments. Clawback practices require pharmacies to collect set copayments that exceed actual cash prices. A $15 copay may apply when the pharmacy's cash price equals $8.

Not checking if negotiated prices apply to your plan

Negotiated Medicare prices affect beneficiaries differently based on individual plan structures. Formulary tier placement and cost-sharing arrangements determine actual savings amounts. Annual formulary modifications include medication removals and additional coverage restrictions.

Overlooking discount cards for Medicare beneficiaries

Discount platforms like GoodRx or Inside Rx remain available to Medicare enrollees when paying cash rather than using Part D benefits. Federal Anti-Kickback statutes prohibit manufacturer coupons for Medicare participants. Third-party discount programs offer legitimate alternatives when their pricing beats plan costs.

Failing to compare prices annually during open enrollment

Medicare formularies covered three-quarters of FDA-approved drugs in 2010 compared to approximately half currently. Annual coverage reviews generate average savings of $300 or more during open enrollment periods. Medication changes, health status modifications, and evolving plan options require systematic price comparison each enrollment cycle.

The Inside Rx prescription discount card works like a coupon to save on the cost of prescription medication at your local pharmacy.

Jardiance

^$ 392.35

Tablet, 25 Mg

30 Tablets

Ozempic

^$ 349.00

Pen Injector, 1/0.75(3) (Package Of 3.0 Ml)

1 Package

Conclusion

Prescription costs demonstrate substantial variations across pharmacy locations, establishing price comparison as the primary method for reducing medication expenditures. Medicare's negotiated pricing structure generates significant cost reductions for selected medications, yet additional savings opportunities exist beyond these standard arrangements. Price comparison platforms including Inside Rx, GoodRx, and Medicare Plan Finder reveal cost optimization possibilities that extend past conventional insurance coverage structures.

Generic medication selection over brand-name alternatives, multi-pharmacy price verification, and annual coverage evaluation during open enrollment periods produce savings ranging from hundreds to thousands of dollars annually. Discount card utilization frequently outperforms insurance copayment structures, particularly for patients who have not reached deductible thresholds. Price comparison implementation begins immediately and delivers quantifiable prescription cost reductions.

References

Topics:

Prescription Savings Health Tips for Women Health Tips for Men